Bath & Body Works, Inc. (NYSE:BBWI) Shares Bought by Janus Henderson Group PLC

Janus Henderson Group PLC boosted its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 15.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,296,280 shares of the company’s stock after acquiring an additional 174,760 shares during the period. Janus Henderson Group PLC owned about 0.60% of Bath & Body Works worth $50,256,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in BBWI. Fifth Third Wealth Advisors LLC raised its position in Bath & Body Works by 4.9% in the 4th quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company’s stock valued at $271,000 after purchasing an additional 324 shares during the last quarter. SRS Capital Advisors Inc. raised its position in Bath & Body Works by 99.7% in the 4th quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock valued at $26,000 after purchasing an additional 329 shares during the last quarter. UMB Bank n.a. raised its position in Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after purchasing an additional 335 shares during the last quarter. Lindbrook Capital LLC raised its position in Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after purchasing an additional 431 shares during the last quarter. Finally, Cornerstone Investment Partners LLC raised its position in Bath & Body Works by 3.8% in the 4th quarter. Cornerstone Investment Partners LLC now owns 12,248 shares of the company’s stock valued at $475,000 after purchasing an additional 452 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the stock. The Goldman Sachs Group reduced their price target on shares of Bath & Body Works from $49.00 to $42.00 and set a “buy” rating for the company in a research report on Tuesday, April 22nd. Barclays cut their price objective on shares of Bath & Body Works from $38.00 to $31.00 and set an “equal weight” rating for the company in a research report on Monday. JPMorgan Chase & Co. cut their price objective on shares of Bath & Body Works from $47.00 to $41.00 and set an “overweight” rating for the company in a research report on Monday, April 14th. Cowen restated a “buy” rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Finally, Citigroup cut their price objective on shares of Bath & Body Works from $48.00 to $36.00 and set a “buy” rating for the company in a research report on Monday, April 7th. Four analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $41.44.

Bath & Body Works Stock Up 0.7%

Shares of BBWI opened at $33.68 on Wednesday. The company has a 50-day simple moving average of $29.80 and a 200-day simple moving average of $33.86. The company has a market capitalization of $7.17 billion, a PE ratio of 8.21, a P/E/G ratio of 0.92 and a beta of 1.87. Bath & Body Works, Inc. has a 52-week low of $24.96 and a 52-week high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. The business had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. On average, research analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works announced that its Board of Directors has approved a share buyback plan on Thursday, February 27th that allows the company to repurchase $500.00 million in outstanding shares. This repurchase authorization allows the company to repurchase up to 6.4% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s management believes its shares are undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.